Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Understanding needs of people with Multiple Sclerosis. Perspective of patients and significant others in the German-speaking part of Switzerland].
Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.
Disability Identity Predicts Lower Anxiety and Depression in Multiple Sclerosis.
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Effects of Three Months Fingolimod Therapy on Heart Rate.
Role of SFB in autoimmune arthritis: An example of regulation of autoreactive T cell sensitivity in the gut.
Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis.
Medical and Nonstroke Neurologic Causes of Acute, Continuous Vestibular Symptoms.
Social disruption alters pain and cognition in an animal model of multiple sclerosis.
Myelin-derived lipids modulate macrophage activity by liver x receptor activation.
Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.
Evoked potentials in multiple sclerosis.
Assessing spinal cord function in multiple sclerosis with functional neuroimaging: insights and limitations.
Imaging Cortical Damage and Dysfunction in Multiple Sclerosis.
Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?
Transverse Myelitis Associated With an Itchy Rash and HyperCkemia: Neuromyelitis Optica Associated With Dermatitis Herpetiformis.
Drug therapy for multiple sclerosis.
C-11Utility of the Ten Item Personality Inventory (TIPI) in Multiple Sclerosis (MS): What Can 10 Items Tell Us?
Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis
An empowerment model of workplace support following disclosure, for people with MS.
Assessment of postural stabilization in three task oriented movements in people with multiple sclerosis.
Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration?
The Gut Microbiome and the Brain.
Significant clinical worsening after natalizumab withdrawal: Predictive factors.
Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.
Pages
« first
‹ previous
…
317
318
319
320
321
322
323
324
325
…
next ›
last »